Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Exploring the Dual Role of Malat1 in Thyroid Tumorigenesis: Oncogenic or Tumor Suppressor? Publisher Pubmed



O Anbiyaee OMID ; F Ghaedrahmati FARHOODEH ; Am Salehi Abdolah MOUSAVI ; A Khodadadi ALI ; B Kempisty BARTOSZ ; M Farzaneh MARYAM ; Mag Dari Mahrokh Abouali GALE
Authors

Source: Current Molecular Medicine Published:2025


Abstract

Thyroid cancer is the most prevalent form of endocrine cancer. Therefore, the administration of new therapeutic agents for thyroid cancer patients is necessary. One of the recent successes in thyroid cancer research is the identification of the role of signaling pathways in the pathogenesis of the disease. Emerging evidence reveals that long non-coding RNAs (lncRNAs) can serve as novel therapeutic approaches for the diagnosis and treatment of thyroid cancer. The lncRNA metastasis-associated lung adenocarcinoma transcript-1 (MALAT1) plays key roles in gene expression, RNA processing, and epigenetic regulation. It is believed that MALAT1 can regulate several cancer-related processes, including tumour cell growth, proliferation, and metastasis. MALAT1 is involved in the pathogenesis of thzroid cancers by targeting multiple downstream targets and miRNA/mRNA axes. Here, we summarize the emerging roles of MALAT1 in this cancer. © 2025 Elsevier B.V., All rights reserved.
Other Related Docs
9. Circular Rnas: New Players in Thyroid Cancer, Pathology Research and Practice (2020)
11. Potential Roles of Lncrna-Xist/Mirnas/Mrnas in Human Cancer Cells, Clinical and Translational Oncology (2023)